Oracle
ORCL
NVIDIA
NVDA
Amazon
AMZN
Adobe
ADBE
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
MDNAF Medicenna Therapeutics
- 0.991
- -0.005-0.45%
15min DelayClose Jan 21 16:00 ET
- 0.970
- -0.020-2.06%
Post 16:28 ET
77.42MMarket Cap-3.74P/E (TTM)
1.008High0.965Low72.64KVolume0.990Open0.995Pre Close72.01KTurnover0.30%Turnover RatioLossP/E (Static)78.16MShares2.20052wk High5.56P/B23.89MFloat Cap0.30352wk Low--Dividend TTM24.12MShs Float6.840Historical High--Div YieldTTM4.27%Amplitude0.151Historical Low0.991Avg Price1Lot Size
Medicenna Therapeutics News
Medicenna Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
Medicenna Therapeutics | S-8 POS: S-8 POS
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.